Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Sodium Channel Blockers - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Sodium Channel Blockers - Pipeline Insight, ...

(MENAFN- GlobeNewsWire - Nasdaq) The sodium channel blockers market presents opportunities in treating conditions like arrhythmias, epilepsy, and neuropathic pain due to their action on sodium ...

Scientists at Apichope Bio Pharmaceutical Co. Ltd., Apichope Pharmaceutical Co. Ltd., Guangzhou Lianrui Pharmaceutical Co. Ltd. and Guangzhou Runlin Pharmaceutical Technology Co. Ltd. have synthesized ...

"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults," the authors wrote. "The bidirectional associations we observed suggest ...

GMRx2 is a combination tablet of telmisartan, an angiotensin II receptor blocker, amlodipine, a dihydropyridine calcium channel blocker and indapamide, a thiazide-like diuretic, available in three ...

Whether you choose food or a quality supplement, understanding the calming, vasodilating power of magnesium can be a simple, ...

High blood pressure, a silent killer affecting millions. 46% of people are unaware that they have it, and 1.4 billion people ...

The startup, which has a pair of medicines in testing and others in development, aims to build the “ultimate coagulation disorders company,” its CEO said.

The surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric ...

Hyperkalemic periodic paralysis (hyperPP), paramyotonia congenita (PC) and PC with myotonia permanens are closely related muscle disorders of genetic origin due to allelic mutations in the muscle ...

Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...